U.S. Application Serial No. 88389799 |
Mark: VABREPTA (STANDARD CHARACTER MARK) |
Owner: Glaxo Group Limited
|
Docket/Reference No. 82774358 |
Issue Date: August 21, 2019 |
On August 16, 2019 , you filed a request to expressly abandon your application after publication and before registration. Your
application is now abandoned and we will take no further action on it. |
|